In the latest trading session, 0.44 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.18. With the company’s most recent per share price at $2.01 changing hands around $0.21 or 11.67% at last look, the market valuation stands at $3.09M. CDT’s current price is a discount, trading about -19402.49% off its 52-week high of $392.00. The share price had its 52-week low at $1.75, which suggests the last value was 12.94% up since then. When we look at Conduit Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.85 million shares, with the 3-month average coming to 638.34K.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Instantly CDT is in green as seen in intraday trades today. With action -27.17%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -70.70%, with the 5-day performance at -27.17% in the red. However, in the 30-day time frame, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -71.77% down. Looking at the short shares, we see there were 3.57 million shares sold at short interest cover period of 0.14 days.

CDT Dividends

Conduit Pharmaceuticals Inc is expected to release its next quarterly earnings report in March.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 49.12% of Conduit Pharmaceuticals Inc shares while 4.06% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.97%.

Among Mutual Funds, the top two as of Oct 31, 2024 were Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund. With 2.33 shares estimated at $4748.0 under it, the former controlled 0.00% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.00% of the shares, roughly 2.03 shares worth around $4127.0.